 | Stoke Therapeutics, Inc. | |||
| NMS : STOK || Location: United States | ||||
$11.66+0.41 (+3.64%) |
1.47 M | 11.07 - 12.04 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.949 M |
| March 15, 2024 | 3.554 M |
| Feb. 29, 2024 | 3.765 M |
| Feb. 15, 2024 | 3.965 M |
| Jan. 31, 2024 | 4.128 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.64 | -0.60 | 6.63% |
| 09/30/2023 | -0.65 | -0.55 | 14.14% |
| 06/30/2023 | -0.65 | -0.69 | -6.30% |
| 03/31/2023 | -0.71 | -0.53 | 25.37% |
| 12/31/2022 | -0.72 | -0.65 | 9.22% |
STOK Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 51.859M | Shares Float | 35.461M |
| Short Float | 4.949M | Market Cap | 583.41M |
| Institution ownership | 88.08% | Insider ownership | 4.642% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.38 | Forward EPS | -2.52 |